IBD research is limited by human interpretation of results. The companies will work together to develop machine learning algorithms to improve on endoscopic clinical trial endpoint assessments.
The ultimate goal is to advance the use of AI for IBD clinical trials.
Jonathan Ng, founder and CEO of Iterative Scopes, said: “This collaboration is an important boost to Iterative Scopes’ efforts to take the collective learnings from the journeys of thousands of patients. Channeling this data into providing the best possible clinical decision for each and every IBD patient.”
More articles on surgery centers:
12-OR ASC part of $295M Florida orthopedic hospital expansion
3 ASCs launching total joint programs
4 ASCs installing total joint robots
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.